Abiopharma

Clinical trial NCT06162663 updates: 1. primary completion date: 2026-02-17 → 2026-01-15 2. enrollment: 5 → 6 participants

Clinical trial NCT06693531 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 350 → 368 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06360289 updates: 1. completion date: 2027-12-01 → 2027-12-15 2. primary completion date: 2027-12-01 → 2027-12-15

Clinical trial NCT05272709 updates: 1. completion date: 2027-06-01 → 2028-04-01 2. primary completion date: 2027-06-01 → 2028-04-01 3. enrollment: 188 → 60 participants

Clinical trial NCT06969170 updates: 1. start date: 2025-05-06 → 2025-05-16 2. completion date: 2026-08-30 → 2028-12-30 3. primary completion date: 2026-06-01 → 2027-12-31

Clinical trial NCT05173350 updates: 1. status: UNKNOWN → COMPLETED 2. primary completion date: 2025-06-01 → 2025-08-18 3. enrollment: 3200 → 3153 participants 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07451951 updates: 1. completion date: 2027-03-31 → 2028-12-31 2. primary completion date: 2026-08-31 → 2028-06-30 3. enrollment: 980 → 1508 participants

Clinical trial NCT05613894: status: SUSPENDED → RECRUITING.

Clinical trial NCT06811909 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 60 → 71 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07217665 updates: 1. status: NOT_YET_RECRUITING → ENROLLING_BY_INVITATION 2. start date: 2026-06-30 → 2026-07-29